Table 1.
Baseline socio-demographic and clinical characteristics.
| Characteristics (N=164) | N (%)* |
|---|---|
| Demographics and psychosocial characteristics | |
| Age (mean [SD]) | 61.5 (10.5) |
| Male sex | 137 (83.5) |
| White | 137 (83.5) |
| Married | 113 (68.9) |
| Living alone | 38 (23.2) |
| Medical history | |
| BMI (mean [SD]) | 28.9 (5.2) |
| Hypertension | 103 (62.8) |
| Diabetes mellitus | 34 (20.7) |
| Hyperlipidemia | 132 (80.5) |
| Current smoking | 21 (12.8) |
| Prior ACS | 69 (42.1) |
| Diagnosis: MI | 88 (53.7) |
| Length of stay (days) | 3 (2.2) |
| Labs (mean [SD]) | |
| Troponin T | 1.5 (3.5) |
| LVEF (n=159) | 0.58 (0.1) |
| Charlson score age adjusted | 3.3 (1.6) |
| Medications at discharge | |
| Aspirin | 159 (96.9) |
| Beta blocker | 144 (87.8) |
| ACEI/ARB | 90 (54.9) |
| Antiplatelet agents | 127 (77.4) |
| Statin | 153 (93.3) |
| Antidepressant | 27 (16.5) |
| Anxiolytic | 16 (9.8) |
| Scores at 2 week visit (mean [SD]) | |
| GQ-6 total (range: 6 – 42) | 36.5 (5.8) |
| MOS-SAS total (range: 4–24) | 16.9 (3.1) |
| SF-12 PCS (range: 0–100) | 40.8 (10.4) |
| SF-12 MCS (range: 0–100) | 50.8 (9.2) |
| PHQ-9 total (range: 0–27) | 4.4 (4.5) |
| HADS-A total (range: 0–21) | 4.3 (4) |
| LOT-R optimism (range: 0–12) | 9.0 (2.9) |
| LOT-R pessimism (range: 0–12) | 8.7 (3.3) |
| LOT-R total (range: 0–24) | 17.7 (5.6) |
| DASI (range:0–58.2) | 38.7 (15.8) |
*
All figures are N (%) unless otherwise specified.
ACEI=Angiotensin-Converting-Enzyme Inhibitor; ACS=Acute Coronary Syndrome; ARB=Angiotensin Receptor Blockers; BMI=Body Mass Index; DASI=Duke Activity Status Index; GQ-6=Gratitude Questionnaire Six Item Form; HADS-A=Hospital Anxiety and Depression Scale—Anxiety Subscale; LOT-R=Life Orientation Test-Revised; LVEF=Left Ventricular Ejection Fraction; MI=Myocardial Infarction; MOS-SAS=Medical Outcomes Study Specific Adherence Scale; PAR=Physical activity recall; PHQ-9=Patient Health Questionnaire-9; SF-12 MCS=Short Form 12 Mental Composite Score; SF-12 PCS=Short Form 12 Physical Composite Score.